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Materials and Methods:
Materials
Fetal bovine serum (FBS) was obtained from Atlanta Biologicals (Lawrenceville, GA).
Peniciline/streptomycin as a mixture (10,000 U/mL), non-essential amino acids (MEM) and Novex® 8%
Tris-Glycine gels were from Invitrogen Life Tech (Carlsbad, CA). Tissue culture flasks, 12-well and 24-well tissue culture plates were purchased from Corning Costar (Corning, NY). Dulbecco's modified Eagle's medium (DMEM), sodium bicarbonate, trypsin-EDTA (10x) solution, cyclosporin A, 4,4'-Isopropylidenediphenol (Bisphenol A), and Hanks' Balanced Salt Solution (HBSS) were from Sigma (St.
Louis, MO). Calcein AM was obtained from Molecular Probes (Eugene, OR). Antihuman P-glycoprotein (C219) mouse monoclonal antibody was from Signet Laboratories (Dedham, MA). Peroxidase-conjugated anti-rabbit and anti-mouse IgG secondary antibodies were obtained from Jackson Immunoresearch (West Grove, PA). ECL Plus Western Blotting Detection System was obtained from Amersham Pharmacia Biotech (Piscataway, NJ). Human P-glycoprotein membranes were purchased from Gentest (Woburn, MA). Microplate fluorescence reader was purchased from Bio-TEK Instruments, Inc (Winooski, VT). All other chemicals were also commercially available.
BeWo Cell Culture
Jin, H. and Audus, K.L. (2005) Effect of bisphenol A on drug efflux in BeWo, a human trophoblast-like cell line. Placenta, 26 Suppl.A, S96-S103. PMID: 15837075. Publisher's official version: http://dx.doi.org/10.1016/j.placenta.2005.01.016. Open Access version: http://kuscholarworks.ku.edu/dspace/. 6 The BeWo clone (b30) was obtained from Dr. Alan Schwartz (Washington University, St. Louis, MO, USA). The cells were cultured as previously described (28) . Briefly, cells were grown in DMEM with 10% heat-inactivated FBS complemented with 0.37% sodium bicarbonate, 100 U/mL of penicillin/streptomycin, 2 mM glutamine and 0.1 mM MEM. The cells were maintained in 75-cm 2 surface area flasks at pH 7.4 under 5% CO 2 and 95% humidity at 37 °C. To pass the cells, the cells were exposed to a trypsin-EDTA solution (0.25% trypsin and 0.02% EDTA in PBS). For uptake assays, cells were plated onto 12-well standard tissue culture plates with a density of 10,000 cells/cm 2 . Cells were used upon forming a confluent monolayer (approximately 5-6 days in culture).
Chronic treatment of BeWo Cells with Bisphenol A
Selected concentrations of BPA were prepared as 1000 x stocks in ethanol. For 48 hr pre-treatment, cells at about 50% confluence were exposed to selected concentrations of BPA. The medium was changed once before use and BPA at the same concentration was included in the change medium. The control cells were cultured in the media containing vehicle (0.1% ethanol) under the same conditions.
Calcein Accumulation Studies
The accumulation studies were performed according to the methods described elsewhere with some modifications (29) . Calcein AM is a substrate for P-gp and calcein, the fluorescent product, has been shown to be a substrate for both P-gp and MRP (30) . The experimental procedures were conducted at 37 °C unless otherwise indicated. Briefly, the BeWo cells at confluence were washed twice with HBSS supplemented with 25 mM D-glucose (HBSS-Glc) followed by the pre-incubation with HBSS- 
Protein Extraction and Western Blot Analysis
The method for membrane isolation was as described previously with some modification (31) .
Briefly, the cells were harvested in Tris-Mannitol buffer [(50 mM Tris-HCl, pH 7.0 containing 300 mM mannitol and 0.5 mM phenylmethylsulfonyl fluoride (PMSF)] followed by centrifugation at 200 x g for 6 min. The cell pellet was lysed by homogenization in TMEP buffer (50 mM Tris, pH 7.0 with HCl, containing 50 mM mannitol, 2 mM EGTA, 10 μg/mL leupeptin, 10 μg/mL aprotinin, 0.5 mM PMSF, 2 μg/mL chymostatin and 2 mM β-mercaptoethanol). Undisrupted cells and nuclear debris were removed by centrifugation at 500 x g for 10 min. The supernatant fluid was centrifuged at 15,000 x g for 15 min at 4°C. The resultant pellet referred to as membrane fraction was then resuspended in TMEP buffer with 30% glycerol (w/v) and the resultant supernatant solution collected was referred to as the soluble fraction. Both fractions were used immediately or saved at -70°C. The proteins from the soluble and membrane fractions were separated on Novex® 8% Tris-Glycine gels followed by western blot assay using anti-human P-gp. The immunoreactive proteins were detected with horseradish peroxidase (HRP) conjugated secondary antibodies and visualized by using an ECL plus chemiluminescence kit. Protein stained by anti-P-gp antibodies were analyzed after scanning and densitometry analysis by OptiQuant image analysis software (Packard Instrument Company). 
Cytotoxicity Assays
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Cell death was assayed 20-24 hours after the treatments by measuring the percentage of lactate dehydrogenase (LDH) released from BeWo cells into the media as described elsewhere (32) . Briefly, the culture medium from the cells, 1 ml in total, was collected. The cells were collected by scraping into a 0.5 ml aliquot of 100 mM potassium phosphate (KP) buffer, pH 7.4. The cell suspension was sonicated for 2 sec. Both the media and cell suspensions were used for LDH efflux assay. The LDH assay mixtures were composed of 0.5 ml of culture media or 0.25 ml of cell suspension, 500 μl sodium pyruvate, and 850 μl of 100 mM KP buffer for media or 1.1 of ml 100 mM KP buffer for cell suspensions. LDH activities were determined by following the changes of absorbance at 340 nm upon addition of β-NADH (1 mg/mL). Release of LDH from the cells was expressed as:
P-gp-ATPase Activity Assay
The P-gp-ATPase activity assay was conducted in a 96-well plate using human P-gp membranes according to the manufacturer's instructions (Gentest, Woburn, MA) with some modification. In brief, all drugs and human P-gp membranes were prepared in Tris-Mes buffer [50 mM Tris-Mes, pH 6.8, 2 mM EGTA, 2 mM dithiothreitol (DTT), 50 mM KCl, and 5 mM sodium azide]. Twenty-microliter of drug solution was loaded onto the plate followed by the addition of an equal amount of P-gp membrane solution (0.25 mg/mL final) with or without sodium orthovanadate (100 μM). The mixture was preincubated at 37 ˚C for 5 min with agitation. The reaction was started by the addition of 5 mM MgATP.
After incubation for 1 hr at 37 ˚C with agitation, the reaction was stopped by adding 30 μl of 10% SDSantifoam A solution. The amount of inorganic phosphate released from the reaction was immediately determined by a colorimetric reaction. The detection reagent containing 2% ascorbic acid (pH 5, freshly prepared), 7 mM ammonium molybdate and 3 mM zinc acetate was added to each finished reaction solution followed by the incubation at 37 ˚C for 1 hr in dark. The absorbance was read at 780 nM.
ATPase activity was determined by the difference in P i levels between 0 min (reaction stopped immediately with SDS) and a 60 min incubation period. To get vanadate-sensitive ATPase activity, P i released in 60 min in the samples with vanadate was subtracted from the samples without vanadate.
ATPase activity was expressed as nmole/mg protein/min.
Cytoplasmic Esterase Activity Assay
BeWo cells grown in 150 cm 2 surface area flasks with about 95% confluence were washed 3 times with 37 ˚C PBS and harvested using a cell scraper. The cell suspension was centrifuged at 450 x g for 6 min and the cell pellet was resuspended in a small amount of PBS. The cell suspension was lysed with sonication followed by centrifugation at 15,000 x g for 20 min. The soluble fraction was collected and used for analyzing endogenous esterase activity. The esterase activity assay was performed in a 96-well black-sided plate. The drugs were loaded in to each well and the reaction was started by the addition of the soluble fraction isolated from cells as described above. The mixture was incubated at 37 ˚C for 45 to 60 min with agitation. The formation of calcein in each sample was determined using a microplate fluorescence reader.
Results
Effect of BPA on Accumulation of Calcein by BeWo Cells
To investigate whether BPA affected drug efflux in BeWo cells, calcein AM was applied to cells with the presence of selected concentrations of BPA or vehicle alone (0.1% ethanol) as a control.
Compared to the control group, the intracellular accumulation of calcein was largely inhibited by BPA in a dose-dependent manner as shown in Figure 1A . These results suggest an activation of the efflux of However, conditions where BeWo cells were acutely treated, a significant decrease in calcein accumulation was typical.
Influence of BPA on P-gp Protein Expression
Although chronic exposure of BeWo cells to BPA did not show significant changes in the functional assays of calcein efflux, we did use immunoblots to assess cytoplasmic and membrane-bound P-gp protein after 48 hr pretreatments. As shown qualitatively in the blot and quantitatively in the density summaries in Figure 1C , high concentrations of 17β-estradiol decreased membrane-and supernatantassociated P-gp in BeWo cells by a very small amount (i.e., approximately 25%). By contrast to the 17β-estradiol effects and probably more consistent with the functional data in Figure 1B , 48 hr pretreatments with high concentrations of BPA increased membrane-and supernatant-associated P-gp in BeWo cells by only a modest amount (i.e., 55%). These results were consistent through three replications of different BeWo cell preparations. Jin 
BeWo Cells
To investigate whether BPA and 17β-estradiol affect drug efflux in a competitive manner, 17β-estradiol was added to the uptake solution along with BPA. As shown in Figure 1D , BPA in the combination of 17β-estradiol appeared to have an additive effect on reducing calcein accumulation.
Like BPA, 17β-estradiol produces a significant, dose-dependent (1 nM to 10 µM) decrease in calcein accumulation (data not shown). To investigate whether the BPA-induced decrease in calcein accumulation could be blocked by CsA, a known P-gp inhibitor (33), CsA was included in our experiments as a potential competitor. Results summarized in Figure 1E show that on addition of CsA alone, calcein accumulation by BeWo cells was increased as expected. In combination with BPA, CsA reverses BPA effects on calcein accumulation by BeWo cells suggesting competition for interactions with P-gP.
BPA and Cytotoxicity in BeWo Cells
Near confluent BeWo cell monolayers were exposed to BPA concentrations ranging from 0.1 μM to 200 μM for 24 hrs. At concentrations of 150 μM or greater, BPA caused marked cell detachment from the culture surface as well as LDH release from the cells that was >20% relative to vehicle (0.1% ethanol) treated cells which exhibited LDH release of <5% of an untreated control (data not shown).
Effect of BPA on P-gp ATPase Activity
Substrates for P-gp generally activate ATPases associated with the protein. P-gp ATPase activity was examined under the conditions indicated in Figure 2 . Verapamil was used as a positive control.
Relative to the positive control and addition of calcein AM as a substrate, BPA did not show any effect on P-gp-ATPase activity. P-gp ATPase activity was greatly inhibited by 200 μM BPA, however that was a concentration found to be cytotoxic by morphological examination and the LDH efflux assay as summarized immediately above.
Effect of BPA on Cytoplasmic Esterase Activity
To determine that BPA does not influence calcein accumulation in BeWo cells by altering release of the fluorescent product, calcein, from calcein AM, cytoplasmic esterase activity was assayed in the soluble portion of BeWo cell lysates. BeWo cell esterase activity in the presence of BPA and representative P-gp and esterase inhibitors is summarized in Figure 3 . Neither BPA nor CsA altered esterase activity associated with calcein generation in BeWo cells. However, 10 mM of paraoxon, an esterase inhibitor, was used as a positive control and was a significant inhibitor of calcein generation by BeWo cells. 
Discussion
A collection of reports suggest very strongly that estrogens and progesterones have significant influence on both the function (20-24) and the expression (34) of multidrug resistance mechanisms. In this study we have examined whether BPA, an environmental estrogen, interacts with P-gp through either altering the efflux mechanism itself or through changes in protein expression. Previously investigators have demonstrated that BPA is at least a substrate for P-gp in the intestine (25) , although no evidence previously existed to indicate that BPA may influence expression of the P-gp protein.
We were able to establish in this study that BPA indeed does have an influence on P-gp as evidenced by a significant decrease in calcein accumulation in BeWo cells treated acutely with the agent. Moreover, we showed that pretreatment of BeWo cells for 48 hours had little effect on calcein accumulation. These results suggest a direct stimulatory action of BPA on the efflux mechanism. This was further supported in part by immunoblots which showed very small increases in membrane-and supernatant-associated P-gp. Similar findings were recently reported where an increase occurred in
ERα positive cells treated with 17β-estradiol (35) . It is noteworthy that in this BeWo cell clone, 17β-estradiol had no such effect on cytosolic P-gp expression. Preliminary immunoblot work in our laboratory shows that this BeWo clone highly expresses ERβ and is apparently negative for ERα and may provide an explanation for the lack of the 17β-estradiol effect in this cell line. The fact that BPA has modest effects on P-gp in contrast to 17β-estradiol would suggest different mediating mechanisms are involved in the BeWo cells. Overall BPA has a low affinity for estrogen receptors relative to 17β-estradiol and therefore also points to the likelihood of other mechanisms. In the literature, BPA was
shown to activate at least nine nuclear receptors in murine placenta, including ERβ in the placenta of only male fetuses (36) . BPA at 10 μM can significantly increase drug metabolism via stimulating the human orphan nuclear receptor-mediated transcription in HepG2 cells. Specifically, cytochrome P450 type 3A4 through PXR/SXR which also is known to mediate P-gp expression (37). Consequently, extensive confirmatory studies will be necessary to examine how BPA and 17β-estradiol might influence P-gp expression through nuclear receptor mechanisms.
The acute presence of BPA was able to greatly stimulate drug efflux activity suggesting that there might be a direct interaction between BPA and drug efflux transporter. In this study, we looked at whether BPA competes for 17β-estradiol efflux. We found instead that BPA in the combination with 17β-estradiol inhibited, apparently in an additive manner, the accumulation of calcein. This may suggest interaction of the two agents in concert at the same site on P-gp, although interaction with more than one site is also possible (21) . The fact that BPA's effects were strongly reversed by CsA, a strong P-gp inhibitor and substrate, suggests that BPA is altering the efflux of calcein AM and calcein by the BeWo cells. Shapiro et al. (21) has shown that studies can be developed to elucidate binding site interactions on P-gp and that is an objective of future studies with BPA and the natural steroid hormones in the trophoblast.
We ruled out BPA induced changes in toxicity to explain our observations for calcein accumulation in BeWo cells. BPA for instance was found to be no more cytotoxic to BeWo cells than other cell types. Cell damage was measured using LDH efflux assays and observed only at concentrations (>150 µM) well above those used in these studies for examining P-gp activity. Similar results were obtained in TM4 cells when after a 16 hr exposure to 200 μM of BPA, cell viability was dramatically decreased (38) .
Calcein AM was used in this study because it is cell membrane permeable, non-fluorescent, and a substrate for P-gp. Once calcein AM enters the cell, it is cleaved by cytoplasmic esterases to form the non-membrane permeant, and fluorescent calcein which is used to estimate drug accumulation in cells (39) . In order to exclude the possibility that the decrease in calcein accumulation by BeWo cells might be due to the inhibition of cytoplasmic esterase activity, esterase assays were performed as part of our investigation. As indicated by our results, BPA did not significantly alter the metabolism of calcein AM to calcein.
Many substrates and modulators of P-glycoprotein have been shown to stimulate or inhibit vanadate-sensitive associated ATPases (31, 40, 41) . As a consequence we examined that characteristic for BPA over a wide concentration range (100 nM to 10 μM). BPA was found not to alter P-gp ATPase activity in this study. This observation was unusual but not unlike observations made by others. For example, in the membrane vesicles from Sf9 cells infected with MDR-baculovirus, estradiol-17β (β-Dglucuronide), coincidentally a metabolite of estradiol, was identified as an endogenous substrate for Pgp. However, estradiol-17β (β-D-glucuronide) neither stimulated P-gp ATPase activity nor inhibited verapamil-stimulated ATPpase activity when applied at the concentration as high as 100 μM (42) .
Sharom (43) has also questioned whether drug-stimulated ATPase activity is representative of the transport function of P-gp.
The fact that our results thus far suggest that BPA can stimulate the export of drugs from cells without activating P-gp ATPase activity raises a number of possibilities in terms of mechanistic explanation. First, the possibility of involvement of MRP might be considered since calcein AM is known to be transported by P-gp and calcein can be transported by both P-gp and MRP1 (30) . However, we
have been unable to demonstrate functional MRP1 in this BeWo clone (27) and as shown here, and CsA strongly reversed BPA's effects on calcein accumulation. A second possibility is that BPA activation of P-gp could be due to a conformational change which allows calcein AM to be more easily accessed by the transporter. On P-gp, at least three drug binding sites are identified, namely as H site selective for
Hoechst 33342 and cochicine, R site selective for rhodamine 123 and anthracyclines and P site for progesterone (21, 44) . Progesterone was found not to be transported by P-gp (34, 45) . It has been Future studies will require direct assay of BPA to further explore the mechanisms by which this agent interferes with P-gp and transverses the placenta.
In summary, in our present study, BPA appeared to directly stimulate P-gp. BPA only modestly stimulated P-gp protein expression and the altered expression did not contribute significantly to the transport of calcein. We submit that this study forms the basis for further exploration of BPA interactions with trophoblast transport mechanisms and for developing a better understanding of how the P-gp is regulated by endogenous and exogenous steroids. 
